CASI Pharmaceuticals

SEC Filings

SEC Filings

View all SEC filings, View only Section 16 SEC filings
Please note that the above are links to www.sec.gov, a third-party web site. CASI Pharmaceuticals, Inc. does not maintain nor provide any information directly to www.sec.gov, and therefore makes no representations or warranties regarding the information contained therein. Further, CASI Pharmaceuticals, Inc. takes no responsibility for supplementing, updating, or correcting any information found on www.sec.gov.

Financial Reports

Date Form Description Web
May 15, 2019 10-Q Quarterly Report
March 29, 2019 10-K Annual Report
November 14, 2018 10-Q Quarterly Report
August 14, 2018 10-Q Quarterly Report
May 15, 2018 10-Q Quarterly Report
March 29, 2018 10-K Annual Report
November 14, 2017 10-Q Quarterly Report
August 14, 2017 10-Q Quarterly Report
May 15, 2017 10-Q Quarterly Report
March 31, 2017 10-K Annual Report
November 14, 2016 10-Q Quarterly Report
August 15, 2016 10-Q Quarterly Report
May 13, 2016 10-Q Quarterly Report

About Us

CASI is a U.S. NASDAQ-listed biopharmaceutical company with a platform to develop and accelerate the launch of pharmaceutical products and innovative therapeutics in China, U.S., and throughout the world. We have offices in Rockville, Maryland, and a wholly owned subsidiary in Beijing, China through which substantially all of our operations are conducted.

Learn More

Presentation

2019 Annual Meeting Presentation

Download →

Presentation

BIO International Convention Presentation

Download →